← FDA DRUG APPROVALS

FDA ANDA · ANDA078214

DANAZOL

Sponsor: LANNETT

APPLICATION
ANDA078214
TYPE
ANDA
ORIGINAL APPROVAL
2007-04-19
LATEST ACTION
2012-03-15
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Prescription

Products

DANAZOLPrescription
DANAZOL 50MG · CAPSULE · ORAL
DANAZOLPrescription
DANAZOL 100MG · CAPSULE · ORAL

Approval history

2012-03-15Labeling · Supplement 2AP
2007-10-29Labeling · Supplement 1AP
2007-04-19OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →